Pringle maneuver exacerbates systemic inflammatory response and multiple-organ injury induced by extended liver radiofrequency ablation

Human and Experimental Toxicology

Volumn 30, Issue 11, 2011, Pages 1855-1864

  Ypsilantis, Petros ^a   Lambropoulou, Maria ^a   Anagnostopoulos, Constantinos ^a   Tsigalou, Christina ^b   Vasiliadis, Constantinos ^a   Kortsaris, Alexandros ^a   Papadopoulos, Nikolaos ^a   Simopoulos, Constantinos ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY GENERAL HOSPITAL OF ALEXANDROUPOLIS   (Greece)

Author keywords

inflammatory response; liver; organ injury; Pringle; radiofrequency ablation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE EXACERBATION; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER SURGERY; MULTIPLE ORGAN FAILURE; NONHUMAN; POSTOPERATIVE CARE; PRINGLE MANEUVER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; RAT; SURGICAL TECHNIQUE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TISSUE INJURY;

ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CATHETER ABLATION; INTERLEUKIN-6; LIVER; MULTIPLE ORGAN FAILURE; NF-KAPPA B; RATS; RATS, WISTAR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS NORVEGICUS;

EID: 80055047523     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327111401438     Document Type: Article

References (41)

1. Mulier S. Complications of radiofrequency coagulation of liver tumors. Br J Surg. 2002 ; 89: 1206-1222
2. Curley SA. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004 ; 239: 450-458
3. Jansen MC. Adverse effects of radiofrequency ablation of liver tumours in the Netherlands. Br J Surg. 2005 ; 92: 1248-1254
4. Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging. 2005 ; 30: 409-418
5. Bleicher RJ. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol. 2003 ; 10: 52-58
6. Livraghi T. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003 ; 226: 441-451
7. Chapman WC. Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation. Ann Surg. 2000 ; 231: 752-761
8. Schell SR. Pro- and antiinflammatory cytokine production after radiofrequency ablation of unresectable hepatic tumors. J Am Coll Surg. 2002 ; 195: 774-781
9. Ng KK. Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model. Ann Surg Oncol. 2004 ; 11: 650-657
10. Ng KK. Safety limit of large-volume hepatic radiofrequency ablation in a rat model. Arch Surg. 2006 ; 141 (3). 252-258
11. Rossi S, Garbagnati F, De Drancesco I, et al. Relationship between the shape and size of radiofrequency induced thermal lesions and hepatic vascularization. Tumori. 1999 ; 85: 128-132
12. Aschoff AJ. How does alteration of hepatic blood flow affect liver perfusion and radiofrequency-induced thermal lesion size in rabbit liver?. J Magn Reson Imaging. 2001 ; 13: 57-63
13. Chinn SB. Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model. Am J Roentgenol. 2001 ; 176: 789-795
14. Wiersinga WJ. Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver. Br J Surg. 2003 ; 90: 306-312
15. Okaya T, Lentsch AB. Cytokine cascades and the hepatic in lammatory response to ischemia and reperfusion. J Invest Surg. 2003 ; 16: 141-147
16. Yilmaz S. The protective effect of erythropoietin on ischaemia/ reperfusion injury of liver. HPB (Oxford). 2004 ; 6: 169-173
17. Sehirli O. Grape seed extract treatment reduces hepatic ischemia-reperfusion injury in rats. Phytother Res. 2008 ; 22: 43-48
18. Liu DL. Multiple-system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg. 1996 ; 131: 442-447
19. Jiang H. Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats. Surgery. 2007 ; 141: 32-40
20. Ypsilantis P. Protective effect of mesna. J Gastroenterol Hepatol. 2008 ; 24: 623-632
21. Yoshidome H. Interleukin-10 inhibits pulmonary NF-kappaB activation and lung injury induced by hepatic ischemia-reperfusion. Am J Physiol. 1999 ; 277: L919 - L923
22. Takeuchi D. Interleukin-18 exacerbates pulmonary injury after hepatic ischemia/reperfusion in mice. J Surg Res. 2010 ; 158: 87-93
23. Lorente L. Surgical anatomy of the liver in Wistar rats. Surg Res Commun. 1995 ; 17: 113-121
24. Bowles BJ. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg. 2001 ; 136: 864-869
25. Dodd GD. Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome. Am J Roentgenol. 2005 ; 185: 51-57
26. Evrard S. Cytokines pattern after surgical radiofrequency ablation of liver colorectal metastases. Gastroenterol Clin Biol. 2007 ; 31: 141-145
27. Jansen MC. Assessment of systemic inflammatory response (SIR) in patients undergoing radiofrequency ablation or partial liver resection for liver tumors. Eur J Surg Oncol. 2008 ; 34: 662-667
28. Jaeschke J. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic Res Commun. 1991 ; 15: 277-284
29. Zwacka RM. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kB independently of IkB degradation. Hepatology. 1998 ; 28: 1022-1030
30. Colletti LM. Role of tumor necrosis factor-a in the pathophysiologic alternations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest. 1990 ; 85: 1936-1943
31. Yoshidome H. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology. 1999 ; 30: 203-208
32. Yadav SS. L-selectin and ICAM-1 mediate reperfusion injury and neutrophil adhesion in the warm ischemic mouse liver. Am J Physiol. 1998 ; 275: G1341 - G1352
33. Lentsch AB. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology. 1998 ; 27: 1172-1177
34. Jaeschke H.. Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol. 2006 ; 290: G1083 - G1088
35. Friedman M. Radiofrequency ablation of cancer. Cardiovasc Intervent Radiol. 2004 ; 27: 427-434
36. Lu DS. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect. Am J Roentgenol. 2002 ; 178: 47-51
37. Lu DS. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol. 2003 ; 14: 1267-1274
38. Ypsilantis P. Bacterial translocation in a rat model of large volume hepatic radiofrequency ablation. J Surg Res. 2010 ; 161: 250-8
39. Moshage H. Cytokines and the hepatic acute phase response. J Pathol. 1997 ; 181: 257-266
40. Camargo CA. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology. 1997 ; 26: 1513-1520
41. Yoshidome H. Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice. J Surg Res. 1999 ; 81: 33-37